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Abstract 
 Cancer is one of the leading causes of death. Pain is one of the most common, feared, and 
distressing symptoms associated with cancer. Minorities experience more severe pain than non-
Hispanic whites and are more likely to have their pain inadequately assessed and treated. 
Disparities in pain associated with cancer at the end of life are not well understood. This study 
sought to investigate the trajectory of cancer pain in those in an inpatient hospice facility and 
investigated disparities in nursing pain scores.  
 A retrospective chart review was conducted to collect the following data: demographics, 
cancer diagnoses, and nursing pain scores. Those with any type of cancer who died in the 
hospice facility were included. Descriptive statistics were used to describe the sample and high 
and low pain scores during the day shift. An independent t-test was used to examine disparities 
in nursing pain scores between whites and blacks.  
 Results from the study suggest those with cancer experience pain at the end of life, even 
when receiving optimal pain control in an inpatient hospice setting. Pain scores on the first 10 
days after admission to hospice ranged from 0 to 10 with 20% reporting severe pain (pain scores 
8-10) on the day of admission. Significant differences in mean high pain scores were found 
between blacks and whites on days 3 (p= 0.010) and 5 (p= 0.032). Results suggest pain continues 
to be a problem at the end of life in those diagnosed with cancer. Nurses must educate patients 
and families about pain goals in hospice and note that it may not be possible to achieve a 
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Disparities in End of Life Pain: A Pilot Study in Hospice 
Cancer is the second leading cause of death in the United States (U.S. Department, 2017). 
In 2018, approximately 1,735,350 people will be newly diagnosed with cancer and 609,640 will 
die from their disease (American Cancer Society, 2018). North Carolina is ranked eighth in the 
United States for cancer related deaths with approximately 20,380 cancer deaths per year 
(American Cancer Society, 2018). 
Disparities continue to persist in the diagnosis and treatment of cancer. Minorities 
diagnosed with cancer are more likely to be diagnosed at a later stage, have decreased access to 
treatment, and experience lower survival rates (Vallerand, Hasenau, Templin, & Collins-Bohler, 
2005; American Cancer Society, 2018). When insurance status, age, severity of disease, and 
health status are all similar, racial and ethnic minorities are more apt to receive lower-quality 
care than non-Hispanic whites (American Cancer Society, 2018). One of the goals of the U.S. 
Department of Health and Human Services (DHHS) Healthy People 2020 program is to achieve 
health equity, eliminate disparities, and improve the health of all groups (Healthy People 2020, 
2010). Establishing goals related to eliminating disparities has been a part of the Healthy People 
initiative since the year 2000 (Office of Disease Prevention, n.d.). Recognizing and 
acknowledging the existence of health disparities is a means to the end of achieving high quality 
and equal health care for all patients. 
Pain is one of the most commonly experienced symptoms after a diagnosis of cancer 
(American Cancer Society, 2018; Stein, Alcaraz, Kamson, Fallon, & Smith, 2016; McPherson, 
Hadjistavropoulos, Devereaux, & Lobchuk, 2014; McNeill, Reynolds, & Ney, 2007; Martinez, 
Snyder, Malin, & Dy, 2014; Green, Montague, & Hart-Johnson, 2009; Paice & Ferrell, 2011). It 
is estimated more than 75% of patients with an advanced cancer experience pain (Paice & 
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Ferrell, 2011). Pain can have tremendous effects on quality of life, endurance through treatment, 
health status after remission, and the ability to die peacefully (Paice & Ferrell, 2011). As stated 
by the National Institutes of Health (2002), pain is one of the most underreported and untreated 
symptoms associated with cancer. Both nociceptive pain, of the body tissues, and neuropathic 
pain, of the nerves, usually occur with a diagnosis of cancer. Commonly, patients with cancer 
will encounter pain that varies and becomes complex as the disease progresses (McPherson et al., 
2014).  
Disparities in cancer pain and pain management exist. Minorities report more severe pain 
than non-Hispanic whites (Green et al., 2009). Also, minorities are more likely to have their pain 
inadequately assessed and treated (Green et al., 2009). It is known that disparities exist in pain 
management (Meghani et al., 2014; Vallerand et al., 2005; Stein et al., 2016; Mossey, 2011; 
McNeill et al., 2007; Johnson, 2013; Green et al., 2009; Green et al., 2003; Anderson, Green, & 
Payne, 2009). Little is known, however, about possible disparities in the experience of cancer 
pain at the end of life. In a hospice facility during the last days of life, patients are more likely to 
receive scheduled analgesics and PRN medications (Hunnicutt, Tija, & Lapane, 2017). While we 
did not examine disparities within prescribed pain medication regimens, disparities in pain levels 
were examined. Knowledge gained from this study will address gaps related to health disparities 
and pain at the end of life in persons with cancer. 
Review of Literature 
Cancer Pain 
Many symptoms are present with cancer, but pain is the most prevalent symptom (Green, 
Montague, & Hart-Johnson, 2009; National Institutes of Health, 2002). A quarter of patients 
report pain at the time of cancer diagnosis (Paice & Ferrell, 2011). Pain gradually increases as 
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the disease progresses (McNeill et al., 2007). Cancer pain can be an effect of the cancer itself, 
treatment, diagnostic tests and procedures, or other present conditions (McNeill et al., 2007). 
Approximately 33% of patients experience pain while receiving treatment for their cancer (Paice 
& Ferrell, 2011). In cancer survivors, more than 30% of patients continue to report chronic pain 
(Paice & Ferrell, 2011). 
Barriers to Cancer Pain Management  
Several studies have shown multiple barriers to cancer pain management. One study 
conducted by Stein et al. (2016) identified barriers on the patient, provider, and system levels. 
The levels with the greatest disparities were the provider and system levels. Provider-level 
barriers included inadequate assessment of pain, reluctance to prescribe opioids, limited 
knowledge of pain management, and lack of communication skills. System-level barriers 
included resource scarcity or inequalities in the availability of analgesics in pharmacies and high 
costs of pain medications. Patient-level barriers were less significant in this study but can still be 
detrimental to effective pain management. These barriers include adequate communication, 
concerns and misconceptions regarding opioid addiction and side effects, fear of distracting 
physicians, medical mistrust, and belief that pain is inevitable (Stein et al., 2016).  
Two additional studies identified barriers to pain management including: inadequate pain 
assessment, patient reluctance to report pain, inadequate staff knowledge of pain management, 
inadequate communication between physician and patient, physician mistrust, limited 
availability of pain medications in certain settings, and decreased health literacy (McNeill et al., 
2007; Green et al., 2003).  
The existence of barriers within pain management can be one of the causes of unrelieved 
cancer pain (Wilkie et al., 2017). In a study conducted by Wilkie et al. (2017), barriers to cancer 
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pain management were reported by hospice patients and their caregivers. Barriers with the 
highest concern reported by patients included the notion that pain means disease progression and 
constipation from pain medicine. For caregivers, the top barriers to cancer pain management 
were pain means disease progression, constipation, addiction to pain medicines, and pain 
medicine causing confusion or one to do embarrassing things (Wilkie et al., 2017). The belief 
that pain is an uncontrollable companion of disease and addiction is unavoidable may result in 
nonadherence to pain medications and subsequent poor pain control (Wilkie et al., 2017). 
Race Disparities 
Disparities in health care can be defined as differences in the prevalence of diseases, 
health outcomes, and quality and access to care across racial and ethnic groups (Johnson, 2013). 
Many studies have explored these differences among racial groups in relation to cancer and pain 
management. Using qualitative interviews of black patients with advanced cancer, living with 
pain was one of the two themes that arose; with pain deriving from diagnosis, reoccurrence, 
treatment, and everyday life (Yeager, Quest, Vena, & Sterk, 2018). A study conducted by Im et 
al. (2007) supported the notion that ethnicity groups vary in their cancer pain experience. This 
finding has been shown in multiple studies that suggest black patients with cancer have higher 
rates of pain and suffering from symptoms than white patients (Vallerand et al., 2005; Martinez 
et al., 2014; Green et al., 2009).  
Minorities diagnosed with cancer are less likely to be diagnosed at an early stage, receive 
prompt follow up after a positive screening test, and obtain initiation of proper treatment plans 
(Anderson et al., 2009). Moreover, physicians are more likely to underestimate reported pain 
levels in racial and ethnic minority patients (Mossey, 2011). Disparities also exist in analgesic 
prescription patterns. Black patients are more likely to receive a prescription for morphine rather 
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than oxycodone for pain management, while white patients were the opposite (Meghani et al., 
2014). Even after controlling for insurance status, black patients were still more likely to receive 
morphine over oxycodone (Meghani et al., 2014). A review of the literature by Mossey (2011) 
deduced that white patients receive more prescriptions for opioids at higher doses than blacks, 
Hispanic whites, or Asian Americans. Consistent documentation in research has shown 
inadequate treatment of cancer-related pain in minorities (Anderson et al., 2009). 
Gender Disparities 
Data is limited on gender disparities in pain and pain management. A survey conducted 
by Green et al. (2003) showed that women experienced more severe breakthrough pain than men, 
but these disparities were not consistent over time. Only one other known study has shown that 
women were more likely to report pain than men (Bernabei et al., 1998). There have been no 
known studies that investigate specifics of gender disparities in pain and pain management.  
Age Disparities 
Age disparities in pain and pain management is also an area with limited data. It is 
reported that 35-80% of nursing home residents encounter untreated pain (Green et al., 2003). 
Bernabei et al. (1998) conducted a study to evaluate the pain management of elderly and 
minority patients with cancer in nursing homes aged 65 and above. The results showed 26% of 
patients experiencing daily pain received no analgesics to relieve the pain. Out of these patients 
experiencing pain, as their age increased, the proportion of those who did not receive an 
analgesic drug also increased. For those that did receive analgesics for pain, patients that were 
older than 85 years received stronger opioids less frequently than patients in the 65 to 74 year 
category (Bernabei et al., 1998). There have been no other known studies since to research age 
disparities in pain management.  
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Rural/Urban Disparities 
Also contributing to the gap in the literature is rural and urban health disparities. 
Pharmacies in rural areas may not carry medications because of fear of robbery or low demand, 
which causes low availability of needed medications (McNeill et al., 2007). In urban areas, 
disparities may exist due to restricted pharmaceutical formularies because of costs and 
agreements, limited physical space, and excessive mandatory documentation (McNeill et al., 
2007). No known studies have been conducted to explore rural/urban disparities and pain at the 
end of life. 
Summary 
Cancer pain at the end of life can be extremely detrimental to the quality of life of some 
patients, to where it completely interferes with daily functioning (Vallerand et al., 2005). We 
know that almost all patients that are diagnosed with cancer experience pain, but not all pain is 
treated the same. While many patient, provider, and system barriers exist to hamper the pain 
management process, disparities may also exist due to demographic factors. Race, gender, age, 
insurance status, and residing in a rural or urban area may affect pain management. Current 
evidence supports disparities in cancer pain management, but relatively little is known about 
disparities in pain management at the end of life (EOL). 
Research Aims 
The purpose of this study was to examine potential racial disparities in nursing pain scores in 
patients with cancer in the final days prior to death. The specific aims for the proposed study 
were: 
1) To determine the trajectory of pain during the first 10 days in hospice in a diverse sample 
with cancer enrolled in an inpatient hospice facility. 
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2) To examine race related disparities in nursing pain scores in a diverse sample with cancer 
enrolled in an inpatient hospice facility. 
Methods 
A retrospective chart review was conducted at a general inpatient hospice facility in the 
southeastern United States. A convenience sample of medical records were used. Those who 
were admitted to the facility after August 1, 2017 with any type of cancer diagnosis were eligible 
to be included. Those who were discharged to home or another facility while still alive were 
excluded. Patients who die in the inpatient hospice setting have pain closely managed by highly 
skilled nurses and physicians. Therefore, it can be expected these patients receive optimal pain 
management at the end of life.  
Data was retrieved by a nursing student and a PhD prepared nurse. To ensure accuracy of 
the data, 20% of the data collected was reviewed by both researchers. Data retrieved included: 
age, gender, race, geographical location of residence, insurance status, and cancer diagnosis. 
Additional collected data included high and low pain scores for every shift during the patient’s 
admission. Data was entered and stored in REDCap, a secure online data management system.  
Pain scores are recorded by the nursing staff at various intervals during each shift as 
clinically necessary. To control for the variation in times pain was reported, the high and low 
pain scores for each day shift were recorded. When able, patients self-report pain scores to the 
nurse by ranking pain on a 0 to 10 scale. When patients are no longer able to self-report pain 
scores, nurses use the Pain Assessment in Advanced Dementia (PAINAD) Scale to determine the 
level of pain and record a number between 0 and 10.  
The day shift was defined as 7:00 AM to 7:00 PM. Only day time pain scores were used 
in this analysis as this is when patients and hospice staff are most active. Zip codes retrieved 
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from the medical records were used to determine if the person lived in an urban or rural county. 
The National Center for Health Statistics (NCHS) urban-rural classification for counties was 
used to organize counties. Counties classified by NCHS as large-central metro, large-fringe 
metro, medium metro, and small metro were considered urban counties. Counties classified as 
micropolitan and noncore were considered rural counties. Analysis of the data was conducted 
using descriptive statistics and an independent t-test. 
Results 
 A total of 50 records were reviewed for this study (see Appendix A). The mean age was 
63.92 (SD = 13.2) years and 46% of the sample was black. The majority of the sample was 
female (58%), resided in a federally designated urban county (58%), and covered by Medicare 
insurance (58%). Although all types of cancer were included, the majority of the sample was 
diagnosed with lung cancer (34.7%), breast cancer (16.3%), or head and neck cancer (10.2%). 
The average number of days spent in hospice was 4.94 (25th percentile = 1 day, 75th percentile = 
7.25 days) days. 
 High and low nursing pain scores for day shifts were analyzed using descriptive statistics 
(see Appendix B). We analyzed high pain scores on the day shift for the first 10 days of 
admission. High pain scores on day shift ranged from 0 to 10 and low pain scores on day shift 
ranged from 0 to 10. While the general trend of pain at the end of life in hospice should be 
decreasing, the average high pain scores during the last shifts before patients’ deaths increased 
(see Figure 1).  
 Mean high pain scores for the final five days of life were used to compare nursing pain 
scores between whites and blacks (see Appendix C). This range was selected because the 
majority of those included in the study were in hospice for 5 days or less (mean days in hospice 
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= 4.94 days). By day 5, only 26 participants were still alive. Significant differences in mean high 
pain scores were found between blacks and whites on days 3 (p= 0.010) and 5 (p= 0.032).  
Discussion 
This study was designed to explore the potential disparities that exist in nursing pain 
scores in patients with cancer at the end of life. We examined average high and low pain scores 
and conducted preliminary comparisons between blacks and whites.  
Findings from this study indicate that even in an inpatient hospice facility, patients with 
cancer experience pain at the end of life. The high and low pain scores during the first 10 days of 
admission ranged from 0 to 10, meaning patients experienced moderate and severe levels of pain, 
even in an inpatient hospice setting. This supports previous findings by Paice and Ferrell (2011) 
that 75% of people with advanced cancer experience pain. The cause of this pain experience is 
unknown and could have multiple origins, whether patient-related or provider-related.  
By day 5 of admission, only 26 participants were still alive, therefore, nearly half of the 
sample was not able to receive the full benefits of pain management in the inpatient hospice 
facility. This is concerning because 20% of participants rated their pain as an 8, 9, or 10 on the 
day of admission to the hospice facility. Due to such limited survival after admission neither the 
participant nor family is able to experience all the advantages that hospice care offers. An 
increase in survival after admission may decrease pain scores at the end of life.  
Patients with all types of cancer were included in the study. This aids the results to be 
generalized to all cancer populations. The majority of the participants, however, were diagnosed 
with lung cancer (34.7%). In North Carolina, where the study population originated, lung cancer 
is estimated to be the highest diagnosed cancer with 8,490 new cases (American Cancer Society, 
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2018). It will also cause the most cancer-related deaths with 5,770 deaths (American Cancer 
Society, 2018). Study results align with regional trends in lung cancer diagnoses and deaths.  
With the significant findings from the t-test analyzing average high pain scores in whites 
and blacks, it is possible that cancer pain may be experienced differently by blacks. This concurs 
with the findings of studies previously conducted (Meghani et al., 2014; Vallerand et al., 2005; 
Stein et al., 2016; Mossey, 2011; McNeill, Reynolds, & Ney, 2007; Johnson, 2013; Green et al., 
2009; Green et al., 2003; Anderson, Green, & Payne, 2009). However, this study is the first 
known quantitative study to investigate cancer pain at the end of life in such a diverse sample. 
Black patients comprised 46% of this study sample. Pain is the most prevalent experience that 
accompanies a cancer diagnosis and minorities experience many disparities in relation to this 
pain and the cancer itself. It is outside the scope of this study to determine the reasons for 
disparities in pain scores at the end of life. There may be differences in patient or nurse reports of 
pain, differences in prescription practices or the administration of analgesic medications, or 
biological differences that contribute to these disparities. 
Limitations 
One limitation of this study was the retrospective design. Data was limited to what was 
recorded in the medical record and data that was missing could not be retrieved. Additionally, 
pain is subjective and ideally should be reported by the patient. When patients are alert, oriented, 
and verbal, subjective pain scores are achieved. When approaching death, sedation increases, and 
pain scores become objective; the nurses then score pain based on nonverbal indicators. 
Subjective pain scores reported by the nurse may not be as accurate as patient pain scores.  
While the study can be generalized to patients experiencing cancer pain, it cannot be 
generalized to those encountering non-malignant pain. Only patients that had a cancer diagnosis 
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were included in the study. Pain experienced by those in hospice who do not have cancer was not 
examined. Therefore, this study cannot be generalized to those with non-malignant pain at the 
end of life. 
Another limitation of the study was the high number of persons who died soon after 
admission to hospice. Nearly half of participants were deceased after 5 days in hospice. This 
study was not able to examine the pain experience of those participants in the days prior to 
enrollment in inpatient hospice and data was often limited to 1 or 2 day shifts. This does not fully 
capture the experience of pain at the end of life.  
Clinical Implications 
Due to the findings of ongoing prevalence of pain in the final days prior to death, the 
absence of pain may be an inappropriate goal to set for patients. Nurses should begin to educate 
and thoroughly discuss pain goals with patients and families at the time of admission. Nurses 
should continue to provide comfort measures, but setting a goal to keep pain at a minimum, 
while still achieving goals for sedation, may be more appropriate. Finally, nurses should 
advocate for enrollment in hospice when it becomes appropriate to increase survival after 
admission and to provide patients and families with the opportunity to experience the full pain 
management benefits of hospice.  
Future Research 
More quantitative studies examining pain at the end of life in such diverse samples are 
needed. Exploration of the possible difference in pain experience in minorities should be studied 
to determine why these disparities were found. Also, studies examining pain in relation to 
sedation scores are needed. As sedation increases, pain control becomes more reliant upon 
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nursing assessments of pain. Adequate pain control is difficult to determine when the person can 
no longer self-report pain.  
Disparities and pain in patients with cancer could be further examined in hospice 
facilities in different geographical locations. Variations in the results may occur if studies similar 
to this one were conducted in areas with different populations. Pain experienced by patients 
without cancer diagnoses could also be studied to identify further possible disparities. 
Intervention studies are needed to address identified disparities in pain in this population.  
Conclusion 
Maintaining comfort and alleviating pain at the end of life is the primary goal in hospice 
patients and their families (Hunnicutt, Tija, & Lapane, 2017). Nursing pain scores in this study 
suggest patients continue to experience severe pain at the time of admission to hospice and in the 
final days of life. The absence of pain may not be a realistic goal in this population. Disparities in 
pain scores at the end of life indicate a need for further investigation into the reasons for these 
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Appendix A 
 
Table 1A. Study Demographics. 
 
 
Table 2A. Types of Cancer Diagnoses in Study Population. 
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Appendix B 
 
Figure 1. Mean High Pain Scores. This figure shows the average high pain scores for all patients 
on day shifts. The vertical lines represent the range of pain scores for the shift. 
 
Figure 2. Mean Low Pain Scores. This figure shows the average low pain scores for all patients 
on day shifts. The vertical lines represent the range of pain scores for the shift. 
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Appendix C 
 
Table 1B. Mean Pain High Scores and Interquartile Ranges for First 5	
